Zobrazeno 1 - 10
of 1 516
pro vyhledávání: '"F, Peyvandi"'
Autor:
W Kuwabara, D Osmond, J Henshaw, S Agarwal, V Newman, C Hermans, W Miesbach, S Pipe, RS Jr, F Peyvandi
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S450-S451 (2023)
Aim: Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) is a gene therapy evaluated in the phase 3 GENEr8-1 trial that provides endogenous factor VIII (FVIII) production to prevent bleeding in people with severe hemophilia A and represents an alternative to
Externí odkaz:
https://doaj.org/article/78bf8564991842fcb0311ed2966289ec
Autor:
MC Ozelo, J Mahlangu, B Madan, J Mason, F Peyvandi, AV Drygalski, G Yamaguti-Hayakawa, TM Robinson, SW Pipe, TT Gener-Eigh
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S451-S452 (2023)
Aims: Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) provides endogenous factor VIII (FVIII) production to prevent bleeding in people with severe hemophilia A. This study evaluated bleeding, FVIII activity and safety outcomes 3 years after receiving val
Externí odkaz:
https://doaj.org/article/073f51b8f2be4bc78410d269a66d55b0
Autor:
G. Assante, A. Tourna, R. Carpani, F. Ferrari, D. Prati, F. Peyvandi, F. Blasi, A. Bandera, A. Le Guennec, S. Chokshi, V. C. Patel, I. J. Cox, L. Valenti, N. A. Youngson
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The gut is of importance in the pathology of COVID-19 both as a route of infection, and gut dysfunction influencing the severity of disease. Systemic changes caused by SARS-CoV-2 gut infection include alterations in circulating levels of met
Externí odkaz:
https://doaj.org/article/95cf68f807d64f16a5c174697d388c7f
Autor:
I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, M. Spreafico, G. Crovetti, E. Volpato, S. Rossini, C. Novelli, S. Gattillo, L. Barcella, M. Salmoiraghi, A. Falanga, F. Peyvandi, Lombardy AREU TMA Network
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA) requiring urgent treatment. Standardization of its diagnosis and optimal management is challenging. This study aimed to evaluat
Externí odkaz:
https://doaj.org/article/be4ac4f7369348abbe5b5a13ea9d8658
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Introduction The European principles of care in haemophilia marked their first decade in 2018. These guiding principles were the beginning of the European Haemophilia Consortium (EHC) review of countries’ adherence to these principles in 2
Externí odkaz:
https://doaj.org/article/075c2364a27e4c2d97c695f247457218
Autor:
F. Fioredda, E. Cappelli, A. Mariani, A. Beccaria, E. Palmisani, A. Grossi, I. Ceccherini, R. Venè, C. Micalizzi, M. Calvillo, F. Pierri, I. Mancini, F. Peyvandi, F. Corsolini, C. Dufour, M. Miano
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3432-3435 (2019)
Externí odkaz:
https://doaj.org/article/ac40eabd38d44e3ba36eae547fbe51f8
Autor:
M. Scully, J. de la Rubia, K. Pavenski, A. Metjian, P. Knöbl, F. Peyvandi, S. Cataland, P. Coppo, J. A. Kremer Hovinga, R. De Passos Sousa, F. Callewaert, S. Gunawardena, J. Lin
Publikováno v:
HemaSphere, Vol 6, Pp 195-196 (2022)
Externí odkaz:
https://doaj.org/article/6a694e355f474a988d59711de7a8c0ac
Autor:
M. Scully, J.L. Rubia, F. Peyvandi, S. Cataland, P. Coppo, J.A.K. Hovinga, P. Knoebl, K. Pavenski, F. Callewaert, J.M.M. Edou, R.P. Sousa
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 95- (2020)
Externí odkaz:
https://doaj.org/article/3e326561299b4ffdafe6286cdcef69c1
Autor:
S. Besisik, J. De La Rubia, F. Peyvandi, M. Scully, S. Cataland, P. Coppo, J. A. Kremer Hovinga, P. Knoebl, A. Metjian, K. Pavenski, H. De Winter, R. De Passos Sousa, F. Callewaert
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 62- (2020)
Externí odkaz:
https://doaj.org/article/0b843b7d47404d37b5797f4239e67af4
Autor:
L. Kaynar, P. Coppo, M. Scully, J. De La Rubia, F. Peyvandi, S. Cataland, J. A. Kremer Hovinga, P. Knoebl, K. Pavenski, J. Minkue Mi Edou, F. Callewaert, R. De Passos Sousa
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 62-63 (2020)
Externí odkaz:
https://doaj.org/article/86642bdc87514c7db7e170709e05ebc8